Global Bitter Melon Peptide market size was valued at USD 156.8 million in 2024. The market is projected to grow from USD 172.4 million in 2025 to USD 298.7 million by 2032, exhibiting a CAGR of 7.2% during the forecast period. This growth is propelled by rising diabetes prevalence and the shift toward plant-based nutraceuticals. Bitter melon peptide, derived from Momordica charantia,...